Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1482 of 5804
-
New hope for PAH: rapid drug therapy aims to reverse heart damage
Disease control OngoingThe primary objective of this study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right ventricular (RV) function and reverse RV remodeling in participants with pulmonary arterial hypertension (PAH).
Phase: PHASE4 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Water over soda in daycare may curb childhood obesity
Prevention CompletedInterventions that promote water consumption in place of sugar-sweetened beverages have shown promise for preventing childhood obesity in schoolchildren. Yet to date, no studies have examined whether applying this approach in childcare centers could help to prevent childhood obes…
Phase: NA • Sponsor: Stanford University • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
New drug LEVI-04 aims to ease knee arthritis pain without opioids
Symptom relief CompletedThis is a phase 2, randomized, double-blind, placebo-controlled trial of multiple doses and multiple administrations of LEVI-04 for the treatment of pain due to osteoarthritis of the knee.
Phase: PHASE2 • Sponsor: Levicept • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New cocktail of drugs takes on Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability and preliminary effectiveness of CC-92480 (BMS-986348) in novel therapeutic combinations for the treatment of Relapsed or Refractory Multiple Myeloma (RRMM).
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 14:08 UTC
-
AI and cap team up to spot hidden colon polyps
Disease control CompletedColorectal cancer is the 2nd most common cause of death by cancer. Screening is therefore essential, with a positive impact for prevention, and in the visualization and removal of colonic adenomas, pre-cancerous lesions of colorectal cancer. The colonic adenoma detection rate (C…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New stent aims to save legs from amputation
Disease control CompletedThis is a prospective, multicenter, single arm study designed to evaluate the safety and efficacy of the Temporary Bare Spur Stent System (Spur Stent System).
Phase: NA • Sponsor: ReFlow Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New injectable treatment shows promise for schizophrenia relapse
Disease control CompletedThis is a prospective, non-interventional, multicentre study designed to collect information about the effectiveness, safety and tolerability of Risperidone ISM in patients diagnosed with schizophrenia who are suffering an acute exacerbation, according to routine clinical practic…
Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug combo aims to improve outcomes for elderly lymphoma patients
Disease control Recruiting nowThis is a phase 2, multicenter, open-label, active-controlled randomized trial to determine efficacy and safety of rituximab/bendamustine (RB) alternating with rituximab/bendamustine/cytarabine (RBAC) compared with standard RB alone in the first-line treatment of elderly patients…
Phase: PHASE2 • Sponsor: Kim, Seok Jin • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New migraine pill offers hope for those who Can't take triptans
Symptom relief CompletedThis study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascu…
Phase: PHASE4 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Low-carb diet may help type 1 diabetes patients keep making some insulin
Disease control CompletedLow Carbohydrate Diet (LCD) (\< 130 g of carbohydrate per day) and ketogenic diet (\< 50 g of carbohydrate per day) are popular among patients with type 1 diabetes (T1D). In most cases, LCD allow a better glycemic control and a important decrease of insulin requirements that cann…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can dupilumab help lungs clear mucus better in asthma?
Disease control Recruiting nowSingle center, randomized, placebo- controlled study to assess change in mucociliary clearance of moderate to severe asthma patients after treatment with dupilumab or placebo.
Phase: PHASE4 • Sponsor: Sally E. Wenzel MD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New peanut allergy vaccine enters human testing – could it end the danger?
Disease control OngoingThis phase I clinical trial is designed to evaluate the safety and tolerability of VLP Peanut in healthy subjects and in subjects with peanut allergy (PA). This clinical trial will evaluate the immunotoxicity profile of VLP Peanut in healthy subjects and assess the immunotoxicity…
Phase: PHASE1 • Sponsor: Allergy Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Cheap steroid could save lives from hospital lung infections
Disease control Recruiting nowThe use of corticosteroids in patients with severe community pneumonia, bacterial infection which kills lots of patients around the world, reduces the mortality of this infection. However, there are no studies with this type of drug regarding hospital-acquired pneumonia. This is …
Phase: NA • Sponsor: Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common steroid tame deadly dengue?
Disease control Recruiting nowThe goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could zapping the brain help people with Alzheimer's speak better?
Symptom relief Recruiting nowAD afflicts over 5.5. million Americans and is one of the most expensive diseases worldwide. In AD the variant in which language functions are most affected are referred to as 'logopenic variant Primary Progressive Aphasia' (lvPPA). Language deficits dramatically impair communica…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 26, 2026 17:26 UTC
-
Can a simple supplement boost birth weight? new study hopes so
Disease control CompletedThe primary aim of the study is to evaluate the effect of fortified balanced energy and protein (BEP) supplementation vs. control (multiple micronutrient supplement, MMS) without targeting and with targeting (either by low prepregnancy BMI or low prepregnancy BMI and inadequate g…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Heart hole migraine sufferers: could blood thinners be the answer?
Symptom relief CompletedMigraine attack is an episodic disorder that affects approximately 12% of the population. Previous studies have shown that 41-48% of migraineur have a combination of patent foramen ovale (PFO). Clinical observational studies have been linking medication therapies which include an…
Phase: PHASE2 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a 7-Day cream replace 4 weeks of treatment for skin cancer?
Disease control Recruiting nowThe investigators will compare the application of two different creams for the treatment of low-risk skin cancers-superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis). 5-Fluorouracil cream is currently FDA approved for the treatment of superficial b…
Phase: PHASE2, PHASE3 • Sponsor: Boston University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New hope for teens battling addiction and trauma: combined therapy shows promise
Disease control OngoingPsychosocial traumatic events during childhood, serve as strong and consistent predictors of substance use problems (SUP) during adolescence and adulthood.PTSD that extends from such trauma often co-occurs with SUP. Despite this well-established link, standard care for adolescent…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to predict sudden death in severe epilepsy
Knowledge-focused OngoingDravet Syndrome (DS) is a severe epileptic encephalopathy, which main cause is mutations of SCN1A, the gene coding for the Nav1.1 voltage-gated sodium channel. DS is characterized by childhood onset, severe cognitive deficit and drug-resistant seizures, including several generali…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC